| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Marjolein Y Berger | |
| Hans de Groot | |||
| Paul L P Brand | |||
| Wytske F Fokkens | |||
| P2860 | cites work | House dust mite avoidance measures for perennial allergic rhinitis | Q24243157 |
| Topical nasal steroids for intermittent and persistent allergic rhinitis in children | Q24246303 | ||
| Sublingual immunotherapy for allergic rhinitis | Q24248657 | ||
| Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care | Q28290072 | ||
| Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys | Q29615415 | ||
| Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature | Q33204109 | ||
| Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials | Q33866705 | ||
| Allergic rhinitis and its impact on asthma | Q34438438 | ||
| Intranasal steroid sprays in the treatment of rhinitis: is one better than another? | Q35605836 | ||
| Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis | Q35669988 | ||
| The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). | Q36216879 | ||
| Sublingual immunotherapy: a comprehensive review. | Q36468537 | ||
| Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). | Q36570549 | ||
| Results of a home-based environmental intervention among urban children with asthma | Q39694109 | ||
| Association between allergic rhinitis and hospital resource use among asthmatic children in Norway | Q39706515 | ||
| Cough and malaise in young children due to allergic rhinoconjunctivitis | Q40503004 | ||
| No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year | Q44278745 | ||
| Rhinitis in 10-year-old children and early life risk factors for its development. | Q44309723 | ||
| Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis | Q44474641 | ||
| Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. | Q44920277 | ||
| Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years | Q46637542 | ||
| Increase in the prevalence of rhinitis among Danish children from 1986 to 2001. | Q50544925 | ||
| Measuring quality of life in children with rhinoconjunctivitis. | Q53582108 | ||
| Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray | Q73401282 | ||
| Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate | Q73401283 | ||
| Evaluation of impermeable covers for bedding in patients with allergic rhinitis | Q73683115 | ||
| Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology | Q77708084 | ||
| Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis | Q79481168 | ||
| Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review | Q80551968 | ||
| EAACI position paper on rhinosinusitis and nasal polyps executive summary | Q81620165 | ||
| Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray | Q83857630 | ||
| P433 | issue | 7627 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rhinoconjunctivitis | Q95590608 |
| P304 | page(s) | 985-988 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Allergic rhinoconjunctivitis in children | |
| P478 | volume | 335 |
| Q49485552 | Applicability of evidence from previous systematic reviews on immunotherapy in current practice of childhood asthma treatment: a GRADE (Grading of Recommendations Assessment, Development and Evaluation) systematic review |
| Q34460983 | Clinical practice guideline: Allergic rhinitis |
| Q38512040 | Getting the basics right resolves most cases of uncontrolled and problematic asthma |
| Q57105477 | Modifiable Risk Factors for Common Ragweed () Allergy and Disease in Children: A Case-Control Study |
| Q53175244 | Optical densitometric measurements of the cornea and lens in children with allergic rhinoconjunctivitis. |
| Q91793462 | Rhinoconjunctivitis among Adolescents in Kuwait and Associated Risk Factors: A Cross-Sectional Study |
Search more.